Drug Shortage Report for DEPO-MEDROL 40 MG/ML
| Report ID | 153221 |
| Drug Identification Number | 00030759 |
| Brand name | DEPO-MEDROL 40 MG/ML |
| Common or Proper name | DEPO-MEDROL 40 MG/ML |
| Company Name | PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | METHYLPREDNISOLONE ACETATE |
| Strength(s) | 40MG |
| Dosage form(s) | SUSPENSION |
| Route of administration | INTRASYNOVIAL INTRAMUSCULAR INTRALESIONAL INTRA-ARTICULAR INTRASYNOVIAL INTRAMUSCULAR INTRALESIONAL INTRA-ARTICULAR |
| Packaging size | 10 x 1mL vial |
| ATC code | H02AB |
| ATC description | CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-01-20 |
| Estimated end date | |
| Actual end date | 2022-08-31 |
| Shortage status | Resolved |
| Updated date | 2022-09-01 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v12 | 2022-09-01 | French | Compare |
| v11 | 2022-09-01 | English | Compare |
| v10 | 2022-06-27 | French | Compare |
| v9 | 2022-06-27 | English | Compare |
| v8 | 2022-05-19 | French | Compare |
| v7 | 2022-05-19 | English | Compare |
| v6 | 2022-02-24 | English | Compare |
| v5 | 2022-01-21 | English | Compare |
| v4 | 2022-01-20 | French | Compare |
| v3 | 2022-01-20 | English | Compare |
| v2 | 2022-01-20 | French | Compare |
| v1 | 2022-01-20 | English | Compare |
Showing 1 to 12 of 12